| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |